Form 8-K - Current report:
SEC Accession No. 0001493152-26-020939
Filing Date
2026-05-01
Accepted
2026-05-01 17:28:11
Documents
13
Period of Report
2026-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38404
2 EX-3.1 ex3-1.htm EX-3.1 24654
3 EX-10.1 ex10-1.htm EX-10.1 54358
  Complete submission text file 0001493152-26-020939.txt   295614

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE btcy-20260501.xsd EX-101.SCH 3020
5 XBRL LABEL FILE btcy-20260501_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE btcy-20260501_pre.xml EX-101.PRE 22362
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3000
Mailing Address 203 REDWOOD PARKWAY SUITE 600 REDWOOD CITY CA 94065
Business Address 203 REDWOOD PARKWAY SUITE 600 REDWOOD CITY CA 94065 (800) 590-4155
BIOTRICITY INC. (Filer) CIK: 0001630113 (see all company filings)

EIN.: 472548273 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-40761 | Film No.: 26933919
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)